Fundz

Aitiologic raises €6.4M in oversubscribed seed funding co-led by Heal Capital and Ananda Impact Ventures to advance its tissue-resolved liquid biopsy platform for preeclampsia detection.

PRIVATESep 15, 2026

Amount Raised

$7.4 Million

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

Dr. Gordon SangheraHeal CapitalAnanda Impact Ventures

Description

Aitiologic, a precision medicine company, closed a €6.4 million (approximately $7.4 million) seed financing round co-led by Heal Capital and Ananda Impact Ventures. The funding will support validation and regulated product development of the Aitios® platform, a multi-modal cell-free DNA platform for first-trimester preeclampsia risk stratification. Dr. Gordon Sanghera, co-founder and former CEO of Oxford Nanopore Technologies, participated as an investor and joined the advisory board

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Aitiologic that raised within 45 days of this round, from Fundz verified event records.

  • Setara Biosciences raised $90M (Series A) on October 30, 2026.
  • StimCardio raised $30M (Series A) on October 29, 2026.
  • Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
  • Tivic raised $85M (Series B) on October 27, 2026.
  • VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
  • Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.

Who to call at Aitiologic, and when

A new round usually means Aitiologic is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aitiologic raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aitiologic, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aitiologic. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aitiologic

About

Aitiologic is a precision medicine company developing tissue-resolved liquid biopsy solutions that combine genomic, epigenomic and fragmentomic information from circulating cell-free DNA with AI-powered interpretation. The company's Aitios® platform infers tissue of origin and characterizes tissue-specific biological changes from a routine blood draw at single-molecule resolution. The lead program applies the platform to preeclampsia risk stratification using first-trimester blood samples, with potential applications extending to earlier disease detection, patient stratification, and therapeutic response assessment across multiple conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aitiologic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsStephan, Co-Founder & CTOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aitiologic's next move

See what Strategic adds

Aitiologic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.